Fairvalue-Calculator Fairvalue-Calculator
EN DE

Costamare Bulkers Holdings (CMDB) Fair Value & Analysis

Industrials · US · Market cap $410M

Price$17.56
Fair Value$24.37
Upside+38.8%
Quality91/100
Evidence: Medium Range $17.31 – $31.43

Fair value as of: Jun 24, 2026

Analysis

Costamare Bulkers Holdings (CMDB) currently trades at $17.56, while our model-based Fair Value estimate is $24.37 — implying the stock looks roughly 38.8% undervalued today. We read business quality at 91/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Costamare Bulkers Holdings Limited engages in the ownership and operation of dry bulk vessels worldwide. As of 16 March 2026, it owns 31 dry bulk vessels. The company was incorporated in 2023 and is based in Monaco.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Costamare Bulkers Holdings (CMDB) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $24.37 versus a price of $17.56 — about +39% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CMDB?
Our 21-model fair value for Costamare Bulkers Holdings is $24.37 (as of Jun 24, 2026), built from audited fundamentals. The current price is $17.56.
What is the quality score of CMDB?
Costamare Bulkers Holdings has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.